Boston Bio Systems Limited

BSE:531458 Stock Report

Market Cap: ₹55.2m

Boston Bio Systems Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Pratik Patil

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO

Pratik Patil

1.3yrs

Tenure

Mr. Pratik Satish Patil is Managing Director & Director of Boston Bio Systems Limited from January 29, 2024.

Leadership Team

NamePositionTenureCompensationOwnership
Pratik Patil
MD & Director1.3yrsno datano data
Manpreet Powani
CFO & Director1.4yrsno datano data
Mandeep Kaur
Company Secretary & Compliance Officerless than a yearno datano data
Kushal Rathore
Additional Executive Directorless than a yearno datano data
Seema Baghel
Additional Executive Directorless than a yearno datano data
Sadhana Patil
Whole Time Directorno datano datano data

0.6yrs

Average Tenure

Experienced Management: 531458's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Pratik Patil
MD & Director1.3yrsno datano data
Manpreet Powani
CFO & Directorno datano datano data
Kushal Rathore
Additional Executive Directorless than a yearno datano data
Seema Baghel
Additional Executive Directorless than a yearno datano data
Sadhana Patil
Whole Time Director1.3yrsno datano data
Aashish Dharmadhikari
Non-Executive Independent Director1.3yrsno datano data
Swati Dhadve
Non-Executive Independent Director1.3yrsno datano data
Ghanshyam Gavali
Non-Executive Independent Director1.3yrsno datano data

1.3yrs

Average Tenure

41yo

Average Age

Experienced Board: 531458's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 22:03
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Boston Bio Systems Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.